Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Therapeutic Advances in Medical Oncology
|
December 26, 2022
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia
Jia Li Low, Elaine Lim, Lavina Bharwani, et al.
Plos One
|
January 26, 2016
Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
Lawrence Soon-U Lee, Kok-Yong Seng, Ling-Zhi Wang, et al.
Neuroscience and Biobehavioral Reviews
|
June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression
Isabella Goodwin, Dominic Oliver, Edward Chesney, et al.
European Journal of Medicinal Chemistry
|
September 14, 2019
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
Alessandro Grillo, Giulia Chemi, Simone Brogi, et al.
Cancers
|
June 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
Valerie Heong, Darwin Tay, Shane Ee Goh, et al.
The Journal of Clinical Psychiatry
|
August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial
David Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Breast Cancer Research and Treatment
|
December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer
Kritika Yadav, Joline Lim, Joan Choo, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists
Fabrizio Micheli, Alessia Bacchi, Simone Braggio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 12, 2025
Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathy
Aishwarya Bandla, Rachel Wong, Priyadharshini Santhanakrishnan, et al.
Targeted Oncology
|
April 15, 2023
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
Cheng E Chee, Melissa Ooi, Soo-Chin Lee, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Therapeutic Advances in Medical Oncology
|
December 26, 2022
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia
Jia Li Low, Elaine Lim, Lavina Bharwani, et al.
Plos One
|
January 26, 2016
Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
Lawrence Soon-U Lee, Kok-Yong Seng, Ling-Zhi Wang, et al.
Neuroscience and Biobehavioral Reviews
|
June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression
Isabella Goodwin, Dominic Oliver, Edward Chesney, et al.
European Journal of Medicinal Chemistry
|
September 14, 2019
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
Alessandro Grillo, Giulia Chemi, Simone Brogi, et al.
Cancers
|
June 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
Valerie Heong, Darwin Tay, Shane Ee Goh, et al.
The Journal of Clinical Psychiatry
|
August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial
David Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Breast Cancer Research and Treatment
|
December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer
Kritika Yadav, Joline Lim, Joan Choo, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists
Fabrizio Micheli, Alessia Bacchi, Simone Braggio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 12, 2025
Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathy
Aishwarya Bandla, Rachel Wong, Priyadharshini Santhanakrishnan, et al.
Targeted Oncology
|
April 15, 2023
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
Cheng E Chee, Melissa Ooi, Soo-Chin Lee, et al.
Page
of 6